Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, July 11, 2023
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
Mon, July 10, 2023
[ Mon, Jul 10th 2023
] - WOPRAI
[ Mon, Jul 10th 2023
] - WOPRAI
[ Mon, Jul 10th 2023
] - WOPRAI
[ Mon, Jul 10th 2023
] - WOPRAI
Charles Zhu Initiated (TARA) at Strong Buy and Held Target at $22 on, Jul 10th, 2023
Charles Zhu of Guggenheim, Initiated "Protara Therapeutics, Inc." (TARA) at Strong Buy and Held Target at $22 on, Jul 10th, 2023.
Charles has made no other calls on TARA in the last 4 months.
There is 1 other peer that has a rating on TARA. Out of the 1 peers that are also analyzing TARA, 0 agree with Charles's Rating of Hold.
This is the rating of the analyst that currently disagrees with Charles
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $23 on, Monday, May 8th, 2023
